Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: Post-hoc analysis from an observational and retrospective study
- Castro-Diaz, D.
- Miranda, P.
- Sanchez-Ballester, F.
- Lizarraga, I.
- Arumí, D.
- Rejas, J.
Revista:
BMC Urology
ISSN: 1471-2490
Año de publicación: 2012
Volumen: 12
Tipo: Artículo
